CFLAR and COVID-19: To examine c-FLIP alterations in COVID-19, we analyzed lung autopsy samples from patients infected by SARS-CoV-2 (COVID-19; n = 23) or affected by bacterial pneumonia (BP; n = 4) or other diseases (NRD; n = 4) (Supplementary information, Table 2A).